Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | CTSL | P07711 | 1/20 | 0.38 |
| ▸ | CTSB | P07858 | 1/20 | 0.38 |
| ▸ | CTSK | P43235 | 1/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.38 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.38 |
| ▸ | DPP4 | P27487 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.36 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.36 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.36 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.36 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.36 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7926231 | 0.91 | EPHX2 (0.39) | BCHEACHENAAACTSLCTSB | |
| SCHEMBL12482253 | 0.75 | CTSL (0.51) | NAAACTSLCTSBCTSKOPRM1 | |
| SCHEMBL20178567 | 0.75 | CTSL (0.51) | NAAACTSLCTSBCTSKOPRM1 | |
| SCHEMBL26088403 | 0.71 | CTSL (0.42) | NAAACTSLCTSBCTSKOPRM1 | |
| SCHEMBL8952292 | 0.71 | BCHE (0.43) | BCHEACHECTSLCTSBCTSK | |
| SCHEMBL741694 | 0.70 | CTSL (0.50) | NAAACTSLCTSBCTSKOPRM1 | |
| SCHEMBL15259415 | 0.70 | CTSL (0.50) | NAAACTSLCTSBCTSKOPRM1 | |
| SCHEMBL741692 | 0.70 | CTSL (0.50) | NAAACTSLCTSBCTSKOPRM1 | |
| SCHEMBL741693 | 0.70 | CTSL (0.50) | NAAACTSLCTSBCTSKOPRM1 | |
| SCHEMBL871908 | 0.69 | NPC1 (0.49) | BCHENAAACTSLCTSBCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3530648-B1 | PROCESS FOR PRODUCTION OF PRECURSOR COMPOUND FOR RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | NIHON MEDIPHYSICS CO LTD (JP) | 2023-11-08 | — | — | EP | disclosed |
| EP-3530648-A1 | PROCESS FOR PRODUCTION OF PRECURSOR COMPOUND FOR RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | NIHON MEDI-PHYSICS CO., LTD (JP) | 2019-08-28 | — | — | EP | disclosed |
| EP-2128130-B1 | PROCESS FOR PRODUCTION OF PRECURSOR COMPOUND FOR RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | NIHON MEDIPHYSICS CO LTD (JP) | 2018-10-10 | — | — | EP | disclosed |
| EP-2646411-B1 | PREPARATION OF PET PRECURSOR | BLUE EARTH DIAGNOSTICS LTD (GB) | 2017-08-16 | — | — | EP | disclosed |
| EP-2655321-B1 | PURIFICATION OF PRECURSOR COMPOUND BY CRYSTALLISATION | GE HEALTHCARE LTD (GB) | 2017-02-15 | — | — | EP | disclosed |
| US-9278916-B2 | Preparation of pet precursor | GE HEALTHCARE LIMITED (GB) | 2016-03-08 | — | — | US | disclosed |
| US-9238596-B2 | Process simplification for precursor compound | GE HEALTHCARE LIMITED (GB) | 2016-01-19 | — | — | US | disclosed |
| US-9061977-B2 | Purification of precursor compound by crystallisation | GE HEALTHCARE LIMITED (GB) | 2015-06-23 | — | — | US | disclosed |
| EP-2655321-A1 | PURIFICATION OF PRECURSOR COMPOUND BY CRYSTALLISATION | GE Healthcare UK Limited (GB) | 2013-10-30 | — | — | EP | disclosed |
| EP-2655320-A1 | PROCESS SIMPLIFICATION FOR PRECURSOR COMPOUND | GE Healthcare UK Limited (GB) | 2013-10-30 | — | — | EP | disclosed |
| US-20100016626-A1 | PROCESS FOR PRODUCTION OF PRECURSOR COMPOUND FOR RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2010-01-21 | — | — | US | disclosed |
| EP-2128130-A1 | PROCESS FOR PRODUCTION OF PRECURSOR COMPOUND FOR RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | Nihon Medi-Physics Co., Ltd. (JP) | 2009-12-02 | — | — | EP | disclosed |
| EP-1893246-A4 | STEREOSELECTIVE SYNTHESIS OF AMINO ACID ANALOGS FOR TUMOR IMAGING | UNIV EMORY (US) | 2009-05-06 | — | — | EP | disclosed |
| JP-2009029709-A | METHOD FOR PRODUCING 5-(3-BENZYLOXYCYCLOBUTANE)HYDANTOIN | TOKUYAMA CORP | 2009-02-12 | — | — | JP | disclosed |
| EP-1893246-A2 | STEREOSELECTIVE SYNTHESIS OF AMINO ACID ANALOGS FOR TUMOR IMAGING | Emory University (US) | 2008-03-05 | — | — | EP | disclosed |
| WO-2007001958-A2 | STEREOSELECTIVE SYNTHESIS OF AMINO ACID ANALOGS FOR TUMOR IMAGING | EMORY UNIVERSITY (US) | 2007-01-04 | — | — | WO | disclosed |
| US-20060292073-A1 | Stereoselective Synthesis of Amino Acid Analogs for Tumor Imaging | EMORY UNIVERSITY (US) | 2006-12-28 | — | — | US | disclosed |
| US-5817776-A | TECHNETIUM 99 COMPLEXES, SINGLE PHOTON EMISSION TOMOGRAPHY | EMORY UNIVERSITY (US) | 1998-10-06 | — | — | US | disclosed |
| US-5808146-A | Amino acid analogs for tumor imaging | EMORY UNIVERSITY (US) | 1998-09-15 | — | — | US | disclosed |
| WO-1997017092-A1 | AMINO ACID ANALOGS FOR TUMOR IMAGING | EMORY UNIVERSITY (US) | 1997-05-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060292073-A1 | Stereoselective Synthesis of Amino Acid Analogs for Tumor Imaging | PAICS, BCAT1, SLC1A5 | BCHE 1473/4885ACHE 4650/4885NAAA 370/4885 |
| US-20100016626-A1 | PROCESS FOR PRODUCTION OF PRECURSOR COMPOUND FOR RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | FUS, SLC43A1, PFAS | BCHE 964/4885ACHE 3218/4885NAAA 665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.